^
9ms
Clinical
|
EGFR (Epidermal growth factor receptor) • BRAF (B-raf proto-oncogene)
|
BRAF V600E • EGFR mutation • BRAF V600
|
Mekinist (trametinib) • Tagrisso (osimertinib) • Tafinlar (dabrafenib)
11ms
NICE
|
BRAF (B-raf proto-oncogene)
|
BRAF V600E • BRAF V600
|
Mekinist (trametinib) • Tafinlar (dabrafenib)
1year
Clinical
|
BRAF (B-raf proto-oncogene)
|
BRAF V600E • BRAF V600
|
Mekinist (trametinib) • Tafinlar (dabrafenib)
1year
Clinical
|
BRAF (B-raf proto-oncogene)
|
BRAF V600E • BRAF V600
|
Mekinist (trametinib) • Tafinlar (dabrafenib)
1year
Clinical
|
BRAF (B-raf proto-oncogene)
|
BRAF V600E • BRAF V600
|
Mekinist (trametinib) • Tafinlar (dabrafenib)
1year
Clinical
|
BRAF (B-raf proto-oncogene)
|
BRAF V600E • BRAF V600
|
Mekinist (trametinib) • Tafinlar (dabrafenib)
1year
Clinical • FDA event
|
BRAF (B-raf proto-oncogene)
|
BRAF V600E • BRAF V600
|
Mekinist (trametinib) • Tafinlar (dabrafenib)
1year
Clinical • FDA event
|
BRAF (B-raf proto-oncogene)
|
BRAF V600E • BRAF V600
|
Mekinist (trametinib) • Tafinlar (dabrafenib)
1year
Clinical
|
BRAF (B-raf proto-oncogene)
|
BRAF V600E • BRAF V600
|
Mekinist (trametinib) • Tafinlar (dabrafenib)
1year
Clinical • Metastases
|
BRAF (B-raf proto-oncogene)
|
BRAF mutation • BRAF V600
|
Mekinist (trametinib) • Tafinlar (dabrafenib)
1year
FDA event
|
BRAF (B-raf proto-oncogene)
|
BRAF V600E • BRAF V600
|
Mekinist (trametinib) • Tafinlar (dabrafenib)
1year
FDA event • Combination therapy • Metastases
|
BRAF (B-raf proto-oncogene)
|
BRAF V600E • BRAF V600
|
Mekinist (trametinib) • Tafinlar (dabrafenib)
1year
Clinical
|
BRAF (B-raf proto-oncogene)
|
BRAF V600E • BRAF V600
|
Mekinist (trametinib) • Tafinlar (dabrafenib)
over1year
FDA event
|
BRAF (B-raf proto-oncogene)
|
BRAF V600E • BRAF V600
|
Mekinist (trametinib) • Tafinlar (dabrafenib)
over1year
Clinical
|
BRAF (B-raf proto-oncogene)
|
BRAF V600E • BRAF V600
|
Mekinist (trametinib) • Tafinlar (dabrafenib)
over1year
Clinical • IO biomarker
|
BRAF (B-raf proto-oncogene)
|
BRAF mutation
|
Opdivo (nivolumab) • Mekinist (trametinib) • Yervoy (ipilimumab) • Tafinlar (dabrafenib)
over1year
Pan tumor
|
BRAF (B-raf proto-oncogene)
|
BRAF V600E • BRAF V600
|
Mekinist (trametinib) • Tafinlar (dabrafenib)